Fundz

Kalohexis Appoints Jeffrey Sherman as Chief Medical Officer

PRIVATEAug 11, 2026

Position

Chief Medical Officer

Company

Kalohexis

Jeffrey Sherman
IllinoisBiotechnologyHealth CareTherapeutics

Description

Kalohexis, Inc. has announced the appointment of Dr. Jeffrey Sherman as its Chief Medical Officer

Quick answer

Kalohexis Appoints Jeffrey Sherman as Chief Medical Officer (August 11, 2026). Kalohexis is based in Illinois, United States.

Who is the new Chief Medical Officer at Kalohexis?
Kalohexis named Jeffrey Sherman Chief Medical Officer, announced August 11, 2026.
What did Kalohexis announce on August 11, 2026?
Kalohexis, Inc. has announced the appointment of Dr. Jeffrey Sherman as its Chief Medical Officer
What does Kalohexis do?
Kalohexis is a clinical-stage biotechnology company shaping the next era of metabolic disease care by harnessing the melanocortin (MC) system, the body's natural regulator of metabolic homeostasis, to help people live...
Where is Kalohexis based?
Kalohexis is based in Illinois, United States.
Which similar companies made leadership changes around the same time?
City Therapeutics (August 11, 2026), EIT Pharma (August 12, 2026), Innate Pharma (August 10, 2026) and Percheron Therapeutics Ltd (August 10, 2026) also announced leadership changes within 45 days of Kalohexis.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Kalohexis, and when

A new leader at Kalohexis brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Kalohexis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Kalohexis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Kalohexis. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Kalohexis

Location

Illinois, United States

About

Kalohexis is a clinical-stage biotechnology company shaping the next era of metabolic disease care by harnessing the melanocortin (MC) system, the body's natural regulator of metabolic homeostasis, to help people live healthier lives. Kalohexis' first- and best-in-class therapeutic peptides are designed to safely and effectively drug central melanocortin-3 and -4 receptors (MC3R/MC4R) to treat many metabolic disorders.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Kalohexis changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Daniel
Senior decision-maker at this company
••••••••@••••••••

See Daniel's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Kalohexis's next move

Learn about Strategic plan

Kalohexis changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.